Kanawha Capital Management’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $30.8M | Sell |
141,755
-325
| -0.2% | -$72.1K | 2.17% | 10 |
|
|
2025
Q4 | $32.5M | Sell |
142,080
-1,025
| -0.7% | -$233K | 2.24% | 9 |
|
|
2025
Q3 | $33.1M | Sell |
143,105
-1,365
| -0.9% | -$278K | 2.29% | 10 |
|
|
2025
Q2 | $26.8M | Buy |
144,470
+465
| +0.3% | +$86.4K | 1.99% | 11 |
|
|
2025
Q1 | $30.2M | Sell |
144,005
-100
| -0.1% | -$19.4K | 2.34% | 9 |
|
|
2024
Q4 | $25.6M | Buy |
144,105
+1,673
| +1% | +$308K | 2.01% | 11 |
|
|
2024
Q3 | $28.1M | Sell |
142,432
-6,414
| -4% | -$1.2M | 2.04% | 10 |
|
|
2024
Q2 | $25.5M | Buy |
148,846
+6,724
| +5% | +$1.11M | 2% | 12 |
|
|
2024
Q1 | $25.9M | Buy |
142,122
+422
| +0.3% | +$72.7K | 2.07% | 10 |
|
|
2023
Q4 | $22M | Sell |
141,700
-8,939
| -6% | -$1.3M | 2.01% | 12 |
|
|
2023
Q3 | $22.5M | Sell |
150,639
-1,192
| -0.8% | -$175K | 2.17% | 9 |
|
|
2023
Q2 | $20.5M | Sell |
151,831
-300
| -0.2% | -$44K | 1.88% | 15 |
|
|
2023
Q1 | $24.2M | Buy |
152,131
+290
| +0.2% | +$44.3K | 2.32% | 7 |
|
|
2022
Q4 | $24.5M | Sell |
151,841
-427
| -0.3% | -$65.5K | 2.41% | 7 |
|
|
2022
Q3 | $20.4M | Sell |
152,268
-1,580
| -1% | -$227K | 2.23% | 8 |
|
|
2022
Q2 | $23.6M | Sell |
153,848
-1,725
| -1% | -$264K | 2.39% | 7 |
|
|
2022
Q1 | $25.2M | Buy |
155,573
+247
| +0.2% | +$35.9K | 2.22% | 7 |
|
|
2021
Q4 | $21M | Sell |
155,326
-3,208
| -2% | -$379K | 1.78% | 15 |
|
|
2021
Q3 | $17.1M | Sell |
158,534
-571
| -0.4% | -$65.2K | 1.58% | 22 |
|
|
2021
Q2 | $17.9M | Sell |
159,105
-272
| -0.2% | -$30.6K | 1.64% | 20 |
|
|
2021
Q1 | $17.2M | Sell |
159,377
-2,441
| -2% | -$261K | 1.68% | 19 |
|
|
2020
Q4 | $17.3M | Buy |
161,818
+960
| +0.6% | +$92.3K | 1.78% | 16 |
|
|
2020
Q3 | $14.1M | Buy |
160,858
+121
| +0.1% | +$11.4K | 1.62% | 19 |
|
|
2020
Q2 | $15.8M | Buy |
160,737
+984
| +0.6% | +$86.6K | 1.95% | 13 |
|
|
2020
Q1 | $12.2M | Buy |
159,753
+1,974
| +1% | +$168K | 1.78% | 17 |
|
|
2019
Q4 | $14M | Buy |
157,779
+9,597
| +6% | +$797K | 1.63% | 21 |
|
|
2019
Q3 | $11.2M | Buy |
148,182
+856
| +0.6% | +$58.7K | 1.46% | 26 |
|
|
2019
Q2 | $10.7M | Sell |
147,326
-3,861
| -3% | -$303K | 1.43% | 27 |
|
|
2019
Q1 | $12.2M | Sell |
151,187
-3,486
| -2% | -$285K | 1.71% | 22 |
|
|
2018
Q4 | $14.3M | Sell |
154,673
-1,361
| -0.9% | -$120K | 2.23% | 11 |
|
|
2018
Q3 | $14.8M | Sell |
156,034
-1,432
| -0.9% | -$136K | 2.05% | 11 |
|
|
2018
Q2 | $14.6M | Sell |
157,466
-1,085
| -0.7% | -$106K | 2.17% | 9 |
|
|
2018
Q1 | $15M | Sell |
158,551
-3,344
| -2% | -$367K | 2.27% | 8 |
|
|
2017
Q4 | $15.7M | Sell |
161,895
-2,167
| -1% | -$204K | 2.29% | 9 |
|
|
2017
Q3 | $14.6M | Sell |
164,062
-3,906
| -2% | -$297K | 2.23% | 7 |
|
|
2017
Q2 | $12.2M | Sell |
167,968
-4,162
| -2% | -$280K | 1.9% | 15 |
|
|
2017
Q1 | $11.2M | Sell |
172,130
-2,125
| -1% | -$134K | 1.79% | 18 |
|
|
2016
Q4 | $10.9M | Sell |
174,255
-4,453
| -2% | -$272K | 1.83% | 19 |
|
|
2016
Q3 | $11.3M | Sell |
178,708
-1,565
| -0.9% | -$101K | 1.89% | 13 |
|
|
2016
Q2 | $11.2M | Sell |
180,273
-1,049
| -0.6% | -$63.9K | 1.87% | 12 |
|
|
2016
Q1 | $10.4M | Buy |
181,322
+3,125
| +2% | +$174K | 1.78% | 17 |
|
|
2015
Q4 | $10.6M | Buy |
178,197
+1,926
| +1% | +$111K | 1.9% | 11 |
|
|
2015
Q3 | $9.59M | Sell |
176,271
-340
| -0.2% | -$22.1K | 1.85% | 15 |
|
|
2015
Q2 | $11.9M | Buy |
176,611
+250
| +0.1% | +$16.3K | 2.1% | 9 |
|
|
2015
Q1 | $10.3M | Buy |
176,361
+840
| +0.5% | +$50.7K | 1.81% | 13 |
|
|
2014
Q4 | $11.5M | Sell |
175,521
-281
| -0.2% | -$17.7K | 2.01% | 9 |
|
|
2014
Q3 | $10.2M | Sell |
175,802
-281
| -0.2% | -$15.6K | 1.85% | 12 |
|
|
2014
Q2 | $9.94M | Buy |
176,083
+160
| +0.1% | +$8.39K | 1.82% | 11 |
|
|
2014
Q1 | $9.04M | Sell |
175,923
-873
| -0.5% | -$44.1K | 1.71% | 15 |
|
|
2013
Q4 | $9.34M | Sell |
176,796
-1,732
| -1% | -$85.1K | 1.78% | 12 |
|
|
2013
Q3 | $7.99M | Buy |
178,528
+5,224
| +3% | +$232K | 1.65% | 15 |
|
|
2013
Q2 | $7.16M | Buy |
+173,304
| New | +$7.58M | 1.57% | 19 |
|
Other funds holding ABBV
VCM
VPM
Kanawha Capital Management's ABBV Position: Q1 2026 in Review
Kanawha Capital Management reduced its AbbVie (ABBV) stake by 0.23% in Q1 2026, selling an estimated $72.1K and leaving 141,755 shares worth $30.8M. The position accounts for 2.17% of the portfolio, ranked #10.
Kanawha Capital Management first reported a position in ABBV in Q2 2013 and has held it in 52 quarters since. The position peaked at $33.1M in Q3 2025. 4,077 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.
- Kanawha Capital Management held 141,755 shares of AbbVie worth $30.8M as of Q1 2026.
- Kanawha Capital Management sold 325 AbbVie shares in Q1 2026, an estimated $72.1K.
- AbbVie made up 2.17% of Kanawha Capital Management's portfolio in Q1 2026, its #10 holding.
- Kanawha Capital Management first reported a position in AbbVie in Q2 2013 and has held it in 52 quarters since.
- Kanawha Capital Management's AbbVie position peaked at $33.1M in Q3 2025.
- 4,077 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.
Based on Kanawha Capital Management's 13F filing for Q1 2026, filed 28 Apr 2026.